Highly potent and moderately potent topical steroids are effective in treating phimosis: A prospective randomized study

Stephen Shei Dei Yang, Chou Tsai Yao, Chang Wu Chia, Ping Liu Shih, Cheng Wang Chung

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Purpose: We report a prospective randomized study comparing the effects of highly potent and moderately potent topical steroids in treating pediatric phimosis. Materials and Methods: A total of 70 boys 1 to 12 years old with phimosis were randomly assigned to receive topical application of either betamethasone valerate 0.06% (a highly potent steroid) or clobetasone butyrate 0.05% (a moderately potent steroid). Parents of the boys were instructed to retract the foreskin gently without causing pain, and to apply the topical steroids over the stenotic opening of the prepuce twice daily for 4 weeks, then for another 4 weeks if no improvement was achieved. Retractibility of the prepuce was graded from 0 to 5. Response to treatment was arbitrarily defined as improvement in the retractibility score of more than 2 points. Results: Mean treatment and followup periods were 4.3 and 19.1 weeks, respectively. The response rates in boys treated with betamethasone valerate and clobetasone butyrate were 81.3% and 77.4%, respectively (p = 0.63). Mean retractibility score decreased from 3.9 ± 1.0 to 1.7 ± 1.1, and 4.2 ± 1.0 to 1.9 ± 1.0 in the betamethasone and clobetasone groups, respectively. Both steroids were effective in all age groups. Pretreatment retractibility score did not affect treatment outcomes. No adverse effect was encountered. Conclusions: Highly potent and moderately potent topical steroids are of comparable effectiveness in treating phimosis. A less potent steroid may be considered first to decrease the risk of the potential adverse effects.

Original languageEnglish
Pages (from-to)1361-1363
Number of pages3
JournalJournal of Urology
Volume173
Issue number4
DOIs
Publication statusPublished - Apr 2005

Fingerprint

Phimosis
Steroids
Prospective Studies
Betamethasone Valerate
Foreskin
Betamethasone
Age Groups
Parents
Pediatrics
Pain
Therapeutics

Keywords

  • Circumcision
  • Penis
  • Phimosis
  • Steroids

ASJC Scopus subject areas

  • Urology

Cite this

Highly potent and moderately potent topical steroids are effective in treating phimosis : A prospective randomized study. / Yang, Stephen Shei Dei; Yao, Chou Tsai; Chia, Chang Wu; Shih, Ping Liu; Chung, Cheng Wang.

In: Journal of Urology, Vol. 173, No. 4, 04.2005, p. 1361-1363.

Research output: Contribution to journalArticle

Yang, Stephen Shei Dei ; Yao, Chou Tsai ; Chia, Chang Wu ; Shih, Ping Liu ; Chung, Cheng Wang. / Highly potent and moderately potent topical steroids are effective in treating phimosis : A prospective randomized study. In: Journal of Urology. 2005 ; Vol. 173, No. 4. pp. 1361-1363.
@article{7f517dfb86a64b119330f4e6b9c0a4ef,
title = "Highly potent and moderately potent topical steroids are effective in treating phimosis: A prospective randomized study",
abstract = "Purpose: We report a prospective randomized study comparing the effects of highly potent and moderately potent topical steroids in treating pediatric phimosis. Materials and Methods: A total of 70 boys 1 to 12 years old with phimosis were randomly assigned to receive topical application of either betamethasone valerate 0.06{\%} (a highly potent steroid) or clobetasone butyrate 0.05{\%} (a moderately potent steroid). Parents of the boys were instructed to retract the foreskin gently without causing pain, and to apply the topical steroids over the stenotic opening of the prepuce twice daily for 4 weeks, then for another 4 weeks if no improvement was achieved. Retractibility of the prepuce was graded from 0 to 5. Response to treatment was arbitrarily defined as improvement in the retractibility score of more than 2 points. Results: Mean treatment and followup periods were 4.3 and 19.1 weeks, respectively. The response rates in boys treated with betamethasone valerate and clobetasone butyrate were 81.3{\%} and 77.4{\%}, respectively (p = 0.63). Mean retractibility score decreased from 3.9 ± 1.0 to 1.7 ± 1.1, and 4.2 ± 1.0 to 1.9 ± 1.0 in the betamethasone and clobetasone groups, respectively. Both steroids were effective in all age groups. Pretreatment retractibility score did not affect treatment outcomes. No adverse effect was encountered. Conclusions: Highly potent and moderately potent topical steroids are of comparable effectiveness in treating phimosis. A less potent steroid may be considered first to decrease the risk of the potential adverse effects.",
keywords = "Circumcision, Penis, Phimosis, Steroids",
author = "Yang, {Stephen Shei Dei} and Yao, {Chou Tsai} and Chia, {Chang Wu} and Shih, {Ping Liu} and Chung, {Cheng Wang}",
year = "2005",
month = "4",
doi = "10.1097/01.ju.0000156556.11235.3f",
language = "English",
volume = "173",
pages = "1361--1363",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Highly potent and moderately potent topical steroids are effective in treating phimosis

T2 - A prospective randomized study

AU - Yang, Stephen Shei Dei

AU - Yao, Chou Tsai

AU - Chia, Chang Wu

AU - Shih, Ping Liu

AU - Chung, Cheng Wang

PY - 2005/4

Y1 - 2005/4

N2 - Purpose: We report a prospective randomized study comparing the effects of highly potent and moderately potent topical steroids in treating pediatric phimosis. Materials and Methods: A total of 70 boys 1 to 12 years old with phimosis were randomly assigned to receive topical application of either betamethasone valerate 0.06% (a highly potent steroid) or clobetasone butyrate 0.05% (a moderately potent steroid). Parents of the boys were instructed to retract the foreskin gently without causing pain, and to apply the topical steroids over the stenotic opening of the prepuce twice daily for 4 weeks, then for another 4 weeks if no improvement was achieved. Retractibility of the prepuce was graded from 0 to 5. Response to treatment was arbitrarily defined as improvement in the retractibility score of more than 2 points. Results: Mean treatment and followup periods were 4.3 and 19.1 weeks, respectively. The response rates in boys treated with betamethasone valerate and clobetasone butyrate were 81.3% and 77.4%, respectively (p = 0.63). Mean retractibility score decreased from 3.9 ± 1.0 to 1.7 ± 1.1, and 4.2 ± 1.0 to 1.9 ± 1.0 in the betamethasone and clobetasone groups, respectively. Both steroids were effective in all age groups. Pretreatment retractibility score did not affect treatment outcomes. No adverse effect was encountered. Conclusions: Highly potent and moderately potent topical steroids are of comparable effectiveness in treating phimosis. A less potent steroid may be considered first to decrease the risk of the potential adverse effects.

AB - Purpose: We report a prospective randomized study comparing the effects of highly potent and moderately potent topical steroids in treating pediatric phimosis. Materials and Methods: A total of 70 boys 1 to 12 years old with phimosis were randomly assigned to receive topical application of either betamethasone valerate 0.06% (a highly potent steroid) or clobetasone butyrate 0.05% (a moderately potent steroid). Parents of the boys were instructed to retract the foreskin gently without causing pain, and to apply the topical steroids over the stenotic opening of the prepuce twice daily for 4 weeks, then for another 4 weeks if no improvement was achieved. Retractibility of the prepuce was graded from 0 to 5. Response to treatment was arbitrarily defined as improvement in the retractibility score of more than 2 points. Results: Mean treatment and followup periods were 4.3 and 19.1 weeks, respectively. The response rates in boys treated with betamethasone valerate and clobetasone butyrate were 81.3% and 77.4%, respectively (p = 0.63). Mean retractibility score decreased from 3.9 ± 1.0 to 1.7 ± 1.1, and 4.2 ± 1.0 to 1.9 ± 1.0 in the betamethasone and clobetasone groups, respectively. Both steroids were effective in all age groups. Pretreatment retractibility score did not affect treatment outcomes. No adverse effect was encountered. Conclusions: Highly potent and moderately potent topical steroids are of comparable effectiveness in treating phimosis. A less potent steroid may be considered first to decrease the risk of the potential adverse effects.

KW - Circumcision

KW - Penis

KW - Phimosis

KW - Steroids

UR - http://www.scopus.com/inward/record.url?scp=15044352454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15044352454&partnerID=8YFLogxK

U2 - 10.1097/01.ju.0000156556.11235.3f

DO - 10.1097/01.ju.0000156556.11235.3f

M3 - Article

C2 - 15758802

AN - SCOPUS:15044352454

VL - 173

SP - 1361

EP - 1363

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 4

ER -